Protocols: Mallinckrodt lands a new corporate campus in NJ; Nutrinia bags a $30M round for oral insulin
Following a string of acquisitions, Mallinckrodt is investing $80 million to create a new campus in New Jersey for its development and sales crew. About 400 staffers will move in to the Somerset Financial Center, 1405-1425 Route 206, in Bedminster in the early part of next year, the company reports. Just days ago Mallinckrodt brought a regenerative med company called Stratatech and its specialty pharma arm has also been buying up marketed products. The company also reports that it is beginning new construction at its manufacturing operations in St. Louis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.